Latest Althea Technologies Stories
In the news release, Pfenex Inc. Awards Althea Technologies a Contract for cGMP Manufacturing of Circumsporozoite Protein from Plasmodium falciparum, a Key Malaria Antigen, issued 24-Oct-2012 by Pfenex Inc. over PR Newswire, we are advised by the company that in the third paragraph, the last sentence should have been a quote attributed to Dr. Annie Mo. This quote is now the fourth paragraph. The complete, corrected release follows: Pfenex Inc. Awards Althea Technologies a Contract for cGMP...
SAN DIEGO, Oct. 24, 2012 /PRNewswire/ -- Pfenex Inc. today announced that it has awarded Althea Technologies a contract for the current Good Manufacturing Practice (cGMP) manufacturing of circumsporozoite protein (CSP) from Plasmodium falciparum, an important and proven component of an effective malaria vaccine. Althea Technologies will implement the cGMP-ready Pf?nex Expression Technology(TM)-based production process that was developed at Pfenex over the past several months....
SAN DIEGO, July 19, 2011 /PRNewswire/ -- Sherpa Clinical Packaging, a privately held provider of Clinical Trial Material management services, hosted a ribbon cutting ceremony today to mark the opening of its newly constructed state-of-the-art, CGMP production facility in San Diego, CA. Sherpa's employees and invited guests celebrated the commissioning of its new facility co-located adjacent to the Althea Technologies campus in Sorrento Valley. As previously announced in March, Sherpa and...
STATE COLLEGE, Pa., July 12 /PRNewswire/ -- Blue Mountain Quality Resources, Inc. (State College, PA) announced today that Althea Technologies has chosen Blue Mountain Regulatory Asset Manager to manage the maintenance, calibration and validation of their assets. "Blue Mountain Regulatory Asset Manager provides a surprising amount of value for its cost," said Stacy Sutton, Director of Engineering at Althea Technologies. "With Blue Mountain Regulatory Asset Manager we'll be able to improve...
